Your browser doesn't support javascript.
loading
Nanoceria Anti-inflammatory and Antimicrobial Nanodrug: Cellular and Molecular Mechanism of Action.
Gomes-da-Silva, Natália Cristina; Corrêa, Luana Barbosa; González, Mariana Martínez; Silva França, Álefe Roger; Rebelo Alencar, Luciana Magalhães; Rosas, Elaine Cruz; Ricci-Junior, Eduardo; Borges Aguiar, Tawanny Kayonara; Noronha Souza, Pedro Filho; Santos-Oliveira, Ralph.
Afiliação
  • Gomes-da-Silva NC; Brazilian Nuclear Energy Commission, Nuclear Engineering Institute, Laboratory of Nanoradiopharmacy and Synthesis of New Radiopharmaceuticals, Rio de Janeiro, 21941906, RJ, Brazil.
  • Corrêa LB; Brazilian Nuclear Energy Commission, Nuclear Engineering Institute, Laboratory of Nanoradiopharmacy and Synthesis of New Radiopharmaceuticals, Rio de Janeiro, 21941906, RJ, Brazil.
  • González MM; National Institute for Science and Technology on Innovation on Diseases of Neglected Populations (INCT/IDPN), Oswaldo Cruz Foundation, Rio de Janeiro, 21041361, Brazil.
  • Silva França ÁR; Laboratory of Applied Pharmacology, Farmanguinhos, Oswaldo Cruz Foundation, Rio de Janeiro, 21041361, Brazil.
  • Rebelo Alencar LM; Brazilian Nuclear Energy Commission, Nuclear Engineering Institute, Laboratory of Nanoradiopharmacy and Synthesis of New Radiopharmaceuticals, Rio de Janeiro, 21941906, RJ, Brazil.
  • Rosas EC; Biophysics and Nanosystems Laboratory, Federal University of Maranhão, Department of Physics, São Luis, 65065690, MA, Brazil.
  • Ricci-Junior E; Biophysics and Nanosystems Laboratory, Federal University of Maranhão, Department of Physics, São Luis, 65065690, MA, Brazil.
  • Borges Aguiar TK; National Institute for Science and Technology on Innovation on Diseases of Neglected Populations (INCT/IDPN), Oswaldo Cruz Foundation, Rio de Janeiro, 21041361, Brazil.
  • Noronha Souza PF; Laboratory of Applied Pharmacology, Farmanguinhos, Oswaldo Cruz Foundation, Rio de Janeiro, 21041361, Brazil.
  • Santos-Oliveira R; Federal University of Rio de Janeiro, School of Pharmacy, Rio de Janeiro 21941900, RJ, Brazil.
Curr Med Chem ; 2024 Jan 23.
Article em En | MEDLINE | ID: mdl-38265391
ABSTRACT

INTRODUCTION:

Nanoceria is a well-known nanomaterial with various properties, including antioxidant, proangiogenic, and therapeutic effects. Despite its potential, there are still aspects that require further exploration, particularly its anti-inflammatory and antimicrobial activities.

METHOD:

The global demand for novel anti-inflammatory and antimicrobial drugs underscores the significance of understanding nanoceria in both contexts. In this study, we evaluated the effect of nanoceria on macrophage polarization to better understand its anti-inflammatory effects. Additionally, we investigated the mechanism of action of nanoceria against Cryptococcus neoformans (ATCC 32045), Candida parapsilosis (ATCC 22019), Candida krusei (ATCC 6258), and Candida albicans.

RESULT:

The results demonstrated that nanoceria can polarize macrophages toward an anti-inflammatory profile, revealing the cellular mechanisms involved in the anti-inflammatory response. Concerning the antimicrobial effect, it was observed that nanoceria have a more pronounced impact on Candida parapsilosis, leading to the formation of pronounced pores on the surface of this species.

CONCLUSION:

Finally, biochemical analysis revealed transitory alterations, mainly in liver enzymes. The data support the use of nanoceria as a potential anti-inflammatory and antimicrobial drug and elucidate some of the mechanisms involved, shedding light on the properties of this nanodrug.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article